We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+13.14%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.69B
AUM Growth
+$474M
Cap. Flow
+$80.4M
Cap. Flow %
1.71%
Top 10 Hldgs %
8.06%
Holding
1,297
New
117
Increased
489
Reduced
309
Closed
101

Top Buys

Rank Stock Value
1
GT icon
Goodyear
GT
+$19.2M
2
ATKR icon
Atkore
ATKR
+$16.5M
3
TRN icon
Trinity Industries
TRN
+$15.4M
4
OI icon
O-I Glass
OI
+$15M
5
VSXY
Victoria's Secret
VSXY
+$14.6M

Top Sells

Rank Stock Value
1
TGNA
TEGNA Inc
TGNA
+$25.2M
2
SKYW icon
Skywest
SKYW
+$15.4M
3
TTMI icon
TTM Technologies
TTMI
+$14.9M
4
PARR icon
Par Pacific Holdings
PARR
+$13M
5
SCS
Steelcase
SCS
+$11.8M

Sector Composition

Rank Sector Weight
1 Financials 27.39%
2 Consumer Discretionary 13.71%
3 Technology 12.21%
4 Industrials 11.36%
5 Energy 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBTB icon
926
NBT Bancorp
NBTB
$2.74B
$304K 0.01%
7,280
-182
-2% -$7.81K
ZVIA icon
927
Zevia
ZVIA
$111M
$301K 0.01%
110,600
WYY icon
928
WidePoint Corp
WYY
$114M
$300K 0.01%
60,740
+213
+0.4% +$865
SFBC
929
Sound Financial Bancorp
SFBC
$111M
$297K 0.01%
6,450
+26
+0.4% +$1.21K
LFMD icon
930
LifeMD
LFMD
$172M
$297K 0.01%
43,700
-15,000
-26% -$124K
ALMS
931
Alumis Inc
ALMS
$3.52B
$294K 0.01%
73,728
AARD
932
Aardvark Therapeutics
AARD
$173M
$292K 0.01%
+22,000
New +$248K
LYEL icon
933
Lyell Immunopharma
LYEL
$360M
$292K 0.01%
18,000
AP icon
934
Ampco-Pittsburgh
AP
$193M
$292K 0.01%
127,535
PEPG icon
935
PepGen
PEPG
$197M
$291K 0.01%
63,000
-28,923
-31% -$46.6K
SRTA
936
Strata Critical Medical Inc
SRTA
$512M
$290K 0.01%
57,300
JILL icon
937
J. Jill
JILL
$283M
$288K 0.01%
+16,800
New +$277K
FENC icon
938
Fennec Pharmaceuticals
FENC
$402M
$287K 0.01%
30,700
+6,500
+27% +$56.3K
MXCT icon
939
MaxCyte
MXCT
$126M
$286K 0.01%
180,800
+55,800
+45% +$97K
RRBI icon
940
Red River Bancshares
RRBI
$659M
$286K 0.01%
4,407
ALTG icon
941
Alta Equipment Group
ALTG
$244M
$285K 0.01%
39,400
MTEX icon
942
Mannatech
MTEX
$9.24M
$284K 0.01%
28,954
SMRT icon
943
SmartRent
SMRT
$272M
$282K 0.01%
200,000
CADL icon
944
Candel Therapeutics
CADL
$776M
$281K 0.01%
55,100
NTWK icon
945
NetSol Technologies
NTWK
$50.6M
$280K 0.01%
58,976
+5,268
+10% +$22K
SAMG icon
946
Silvercrest Asset Management
SAMG
$79.9M
$279K 0.01%
17,702
CLAR icon
947
Clarus
CLAR
$143M
$277K 0.01%
79,207
+190
+0.2% +$687
STEM icon
948
Stem
STEM
$52.7M
$273K 0.01%
15,600
STRR
949
Star Equity Holdings
STRR
$41.7M
$273K 0.01%
24,515
+2,455
+11% +$23.1K
HCAT icon
950
Health Catalyst
HCAT
$128M
$271K 0.01%
+95,000
New +$325K

Similar funds

Bridgeway Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Bridgeway Capital Management held 1,297 positions worth $4.69B, up 11% from $4.21B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Bridgeway Capital Management's Q3 2025 filing shows 117 new, 489 increased, 309 reduced and 101 closed positions. Its largest new stake was Goodyear: 2,042,732 shares worth $15.3M. The largest sale was TEGNA Inc, an estimated $25.2M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bridgeway Capital Management's largest Q3 2025 buy was Goodyear: 2,042,732 shares worth $15.3M.
  • Bridgeway Capital Management added most to Sylvamo in Q3 2025, an estimated $9.75M increase.
  • Bridgeway Capital Management's biggest Q3 2025 reduction was TEGNA Inc, cutting an estimated $25.2M.
  • Bridgeway Capital Management fully exited Par Pacific Holdings in Q3 2025, selling an estimated $13M.
  • Bridgeway Capital Management's ten largest holdings make up 8.1% of its $4.69B portfolio in Q3 2025.
  • Bridgeway Capital Management opened 117 new positions and closed 101 in Q3 2025.
  • Bridgeway Capital Management's portfolio value rose 11% quarter-over-quarter to $4.69B.

Based on Bridgeway Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.